AMPHASTAR UK LTD
Get an alert when AMPHASTAR UK LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£87k
USD 117,881
-3.2% lowest in 3 filed years
Net assets
-£3.6m
USD -4,804,576
+4% vs 2024
Employees
—
Average over period
Profit before tax
-£101k
USD -135,815
+21.7% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Negative shareholders' funds
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | — | — | — | — | |
| Operating profit | £2,775 | -£39,356 | £10,238 | +126% | |
| Profit before tax | -£85,082 | -£128,744 | -£100,790 | +21.7% | |
| Net profit | -£85,082 | -£128,744 | -£100,790 | +21.7% | |
| Cash | £93,104 | £90,388 | £87,481 | -3.2% | |
| Total assets less current liabilities | -£397,715 | -£532,284 | -£597,088 | -12.2% | |
| Net assets | -£3,535,462 | -£3,715,983 | -£3,565,548 | +4% | |
| Equity | — | — | — | — | |
| Average employees | 0 | 0 | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | — | — | — |
Figures converted to GBP from USD at 0.742 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Gearing (liabilities / total assets) | 420.5% | 433.2% | 441.8% | |
| Current ratio | 0.74x | 0.68x | 0.64x | |
| Interest cover | 0.03x | -0.44x | 0.09x |
Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for 12 months from the approval date of the 2025 financial statements, supported by its parent undertaking, Amphastar Pharmaceuticals, Inc. Accordingly, they continue to adopt the going concern basis.”
Group structure
- AMPHASTAR UK LTD · parent
- International Medication Systems (UK) Ltd. 100%
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
6 active · 3 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LIAWATIDEWI, Jacob | Secretary | 2016-05-23 | — | — |
| VISTRA COMPANY SECRETARIES LIMITED | Corporate Secretary | 2016-04-22 | — | — |
| LIAWATIDEWI, Jacob | Director | 2016-04-22 | Mar 1974 | American |
| LUO, Mary | Director | 2016-04-22 | Jul 1949 | American |
| PETERS, William | Director | 2016-04-22 | Aug 1967 | American |
| ZHANG, Jack | Director | 2016-04-22 | Sep 1946 | Chinese |
Show 3 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| LIAWATIDEWI, Jacob | Director | 2016-04-22 | 2016-04-22 |
| SHANDELL, Jason | Director | 2016-04-22 | 2016-04-22 |
| SHANDELL, Jason | Director | 2016-04-22 | 2020-04-10 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Amphastar Pharmaceuticals, Inc | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-22 | Active |
Filing timeline
Last 20 of 45 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2026-08-25 | TM01 | officers | Termination director company with name termination date | |
| 2026-08-25 | TM01 | officers | Termination director company with name termination date | |
| 2026-08-25 | TM01 | officers | Termination director company with name termination date | |
| 2026-08-07 | AA | accounts | Accounts with accounts type full | |
| 2026-03-31 | CH04 | officers | Change corporate secretary company with change date | |
| 2026-03-02 | AD01 | address | Change registered office address company with date old address new address | |
| 2025-09-15 | AA | accounts | Accounts with accounts type full | |
| 2025-04-23 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-03-26 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2025-03-26 | PSC09 | persons-with-significant-control | Withdrawal of a person with significant control statement | |
| 2024-10-28 | AA | accounts | Accounts with accounts type full | |
| 2024-04-24 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-27 | AA | accounts | Accounts with accounts type full | |
| 2023-04-27 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-29 | AA | accounts | Accounts with accounts type full | |
| 2022-04-22 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-29 | AA | accounts | Accounts with accounts type full | |
| 2021-06-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-12-01 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.